Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation.

Saved in:

Bibliographic Details
Title:	Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation.
Authors:	Abraham M; Biokine Therapeutics Ltd, Ness Ziona, Israel., Wald H; Biokine Therapeutics Ltd, Ness Ziona, Israel., Vaizel-Ohayon D; Biokine Therapeutics Ltd, Ness Ziona, Israel., Grabovsky V; Biokine Therapeutics Ltd, Ness Ziona, Israel., Oren Z; Biokine Therapeutics Ltd, Ness Ziona, Israel., Karni A; Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Weiss L; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel., Galun E; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel., Peled A; Biokine Therapeutics Ltd, Ness Ziona, Israel.; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel., Eizenberg O; Biokine Therapeutics Ltd, Ness Ziona, Israel.
Source:	Frontiers in immunology [Front Immunol] 2017 Nov 23; Vol. 8, pp. 1432. Date of Electronic Publication: 2017 Nov 23 (Print Publication: 2017).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1664-3224
DOI:	10.3389/fimmu.2017.01432